The present invention relates to a preparation method for and an application of a chiral spirocyclic phosphine-nitrogen-phosphine tridentate ligand SpiroPNP and an iridium catalyst Ir-SpiroPNP thereof. The chiral spirocyclic phosphine-nitrogen-phosphine tridentate ligand is a compound represented by formula I, or a racemate or optical isomer thereof, or a catalytically acceptable salt thereof, and the main structural feature is a phosphine ligand having a chiral spiro indene skeleton and a large sterically hindered substituent. The chiral spirocyclic phosphine-nitrogen-phosphine tridentate ligand can be synthesized into a chiral starting material from a 7-diaryl/alkylphosphino-7′-amino-1,1′-spirodihydroindenyl compound having a spiro ring skeleton. The iridium catalyst of the chiral spirocyclic phosphino-7′-amino-1,1′-spirodihydroindenyl compound having a sprio ring skeleton. The iridium catalyst of the chiral spirocyclic phosphine-nitrogen-phosphine tridentate ligand is a compound represented by formula II, or a racemate or optical isomer thereof, or a catalytically acceptable salt thereof. The iridium catalyst can be used to catalyze the asymmetric catalytic hydrogenation of carbonyl compounds, and especially in the asymmetric catalytic hydrogenation of simple dialkyl ketones. Said catalyst exhibits high yield (>99%) and enantioselectivity (up to 99.8% ee), thus having practical value.

##STR00001##

In a reaction product of at least one phenol compound with aldehyde(s), the phenol compound(s) reply to formula (II): wherein-R represents a hydrogen atom or a hydrocarbyl group comprising from 1 to 30 carbon atoms, -x is 1 or 2, -R.sup.1 is a linear alkyl or alkenyl group having 15 carbon atoms if x is 1, -R.sup.1 is hydrogen if x is 2, -R.sup.2 represents a hydrogen atom or a hydrocarbyl group comprising from 1 to 30 carbon atoms, and its use as a hydrogen sulphide and/or mercaptans scavenger in hydrocarbon compositions and in water-based compositions such as water-based drilling fluids.

In a reaction product of at least one phenol compound with aldehyde(s), the phenol compound(s) reply to formula (II): wherein-R represents a hydrogen atom or a hydrocarbyl group comprising from 1 to 30 carbon atoms, -x is 1 or 2, -R.sup.1 is a linear alkyl or alkenyl group having 15 carbon atoms if x is 1, -R.sup.1 is hydrogen if x is 2, -R.sup.2 represents a hydrogen atom or a hydrocarbyl group comprising from 1 to 30 carbon atoms, and its use as a hydrogen sulphide and/or mercaptans scavenger in hydrocarbon compositions and in water-based compositions such as water-based drilling fluids.

A method for the enzymatic conversion of a phenol substrate into a corresponding catechol product comprises the step of incubating the phenol substrate with a Ralstonia solanacearum tyrosinase enzyme, or a functional derivative thereof, in a reaction mixture, for a period of time sufficient to allow the enzyme convert at least some of the phenol substrate into the catechol product.

A method for the enzymatic conversion of a phenol substrate into a corresponding catechol product comprises the step of incubating the phenol substrate with a Ralstonia solanacearum tyrosinase enzyme, or a functional derivative thereof, in a reaction mixture, for a period of time sufficient to allow the enzyme convert at least some of the phenol substrate into the catechol product.

An object of the present invention is to provide a compound for modulating expression of Major Histocompatibility Complex Class I (MHC-1) and/or TAP-1, in eukaryotic cells. In certain aspects, the compound is a curcuphenol, a terpene or a cannabinoid. Also provided are a composition that comprises the compound and methods of use thereof, for instance, for augmenting an immune response involving MHC-1 CTL, treating cancer, or treating a disease associated with histone acetylation abnormalities.

A terminally-functionalized derivative of a cashew nut shell liquid (CNSL) compound, a method to form a polymer, and an article of manufacture comprising a polymer derived from the terminally-functionalized CNSL derivative. The terminally-functionalized CNSL derivative has two, three, four, or five reactive functional groups. The polymer is prepared by obtaining CNSL compounds, reacting the CNSL compounds to form the terminally-functionalized CNSL derivative, and polymerizing the terminally-functionalized CNSL derivative.

A terminally-functionalized derivative of a cashew nut shell liquid (CNSL) compound, a method to form a polymer, and an article of manufacture comprising a polymer derived from the terminally-functionalized CNSL derivative. The terminally-functionalized CNSL derivative has two, three, four, or five reactive functional groups. The polymer is prepared by obtaining CNSL compounds, reacting the CNSL compounds to form the terminally-functionalized CNSL derivative, and polymerizing the terminally-functionalized CNSL derivative.

A terminally-functionalized derivative of a cashew nut shell liquid (CNSL) compound, a method to form a polymer, and an article of manufacture comprising a polymer derived from the terminally-functionalized CNSL derivative. The terminally-functionalized CNSL derivative has two, three, four, or five reactive functional groups. The polymer is prepared by obtaining CNSL compounds, reacting the CNSL compounds to form the terminally-functionalized CNSL derivative, and polymerizing the terminally-functionalized CNSL derivative.

The present invention is directed to inhibitors of tyrosinase, pharmaceutical compositions comprising such tyrosinase inhibitors, and methods of making and using the same. Specifically, included in the present invention are compositions of matter comprised of at least one 2,4-dihydroxybenzene analog, which inhibit the activity of tyrosinase and which inhibit the overproduction of melanin.